Northern Trust
SMMT icon

Northern Trust’s Summit Therapeutics SMMT Stock Holding History

Northern Trust’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.23M Buy
633,794
+52,194
+9% +$926K ﹤0.01% 2263
2026
Q1 		$11M Buy
581,600
+53,113
+10% +$859K ﹤0.01% 2013
2025
Q4 		$9.24M Sell
528,487
-17,775
-3% -$334K ﹤0.01% 2124
2025
Q3 		$11.3M Buy
546,262
+14,634
+3% +$355K ﹤0.01% 2043
2025
Q2 		$11.3M Sell
531,628
-312,022
-37% -$7.12M ﹤0.01% 1995
2025
Q1 		$16.3M Sell
843,650
-27,752
-3% -$557K ﹤0.01% 1754
2024
Q4 		$15.6M Buy
871,402
+14,075
+2% +$273K ﹤0.01% 1853
2024
Q3 		$18.8M Sell
857,327
-102,976
-11% -$1.44M ﹤0.01% 1657
2024
Q2 		$7.49M Sell
960,303
-112,411
-10% -$607K ﹤0.01% 2161
2024
Q1 		$4.44M Sell
1,072,714
-35,375
-3% -$141K ﹤0.01% 2544
2023
Q4 		$2.89M Buy
1,108,089
+39,590
+4% +$81.4K ﹤0.01% 2797
2023
Q3 		$2M Buy
1,068,499
+38,457
+4% +$73.3K ﹤0.01% 2941
2023
Q2 		$2.59M Buy
1,030,042
+963,409
+1,446% +$1.76M ﹤0.01% 2861
2023
Q1 		$117K Buy
66,633
+16,139
+32% +$44K ﹤0.01% 4046
2022
Q4 		$215K Buy
50,494
+27,591
+120% +$50.2K ﹤0.01% 3833
2022
Q3 		$27K Buy
+22,903
New +$25.9K ﹤0.01% 4487
2022
Q2 		– Sell
-175,682
Closed -$431K – 4805
2022
Q1 		$431K Sell
175,682
-17,120
-9% -$43.2K ﹤0.01% 3789
2021
Q4 		$518K Sell
192,802
-1,264
-0.7% -$6.08K ﹤0.01% 3800
2021
Q3 		$972K Buy
194,066
+159,811
+467% +$1.15M ﹤0.01% 3568
2021
Q2 		$256K Buy
+34,255
New +$225K ﹤0.01% 4043

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Northern Trust's SMMT Position: Q2 2026 in Review

Northern Trust increased its Summit Therapeutics (SMMT) stake by 9% in Q2 2026, buying an estimated $926K and bringing the position to 633,794 shares worth $9.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2263.

Northern Trust first reported a position in SMMT in Q2 2021 and has held it in 20 quarters since. The position peaked at $18.8M in Q3 2024. 243 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Northern Trust held 633,794 shares of Summit Therapeutics worth $9.23M as of Q2 2026.
  • Northern Trust bought 52,194 Summit Therapeutics shares in Q2 2026, an estimated $926K.
  • Summit Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2263 holding.
  • Northern Trust first reported a position in Summit Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Northern Trust's Summit Therapeutics position peaked at $18.8M in Q3 2024.
  • 243 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.